Selected article for: "ALD mouse model and mouse model"

Author: Tornai, David; Furi, Istvan; Shen, Zu T.; Sigalov, Alexander B.; Coban, Sahin; Szabo, Gyongyi
Title: Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice
  • Document date: 2018_10_29
  • ID: 35jfg45k_35
    Snippet: The clinical progression of ALD is associated with liver fibrosis. (27) Our mouse model of ALD mimics the early phase of the human disease, yet mRNA levels of early fibrosis markers Pro-Col1α and α-SMA were significantly increased in alcohol-fed mice compared to PF controls in the whole-liver samples (Fig. 6A,B) . Induction of these makers was remarkably attenuated in the vehicle-treated group and, importantly, further decreased by the TREM-1 i.....
    Document: The clinical progression of ALD is associated with liver fibrosis. (27) Our mouse model of ALD mimics the early phase of the human disease, yet mRNA levels of early fibrosis markers Pro-Col1α and α-SMA were significantly increased in alcohol-fed mice compared to PF controls in the whole-liver samples (Fig. 6A,B) . Induction of these makers was remarkably attenuated in the vehicle-treated group and, importantly, further decreased by the TREM-1 inhibitory formulations used (Fig. 6A,B) .

    Search related documents:
    Co phrase search for related documents
    • clinical progression and human disease: 1, 2, 3, 4
    • clinical progression and liver fibrosis: 1
    • clinical progression and mouse model: 1, 2, 3
    • clinical progression and mRNA level: 1
    • early phase and human disease: 1, 2, 3, 4, 5, 6, 7
    • early phase and mouse model: 1, 2, 3, 4, 5, 6
    • early phase and mRNA level: 1, 2